Art Mandell

Insider Reports History

Entity
Individual
Location
C/O Maxcyte, Inc., C/O 22 Firstfield Road, Suite 110, Gaithersburg, MD
Signature
/s/ Brian Leaf, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Art Mandell:

Stock Role Class Num Shares Value Price $ Report Date Ownership
MAXCYTE, INC. Director Common Stock 396K $1.94M $4.90 Jun 11, 2024 Direct
MAXCYTE, INC. Director Stock Option (right to buy) 40.7K Jun 11, 2024 Direct

Insider Reports Filed by Art Mandell

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MXCT MAXCYTE, INC. Jun 11, 2024 2 $0 4 Jun 13, 2024 Director
MXCT MAXCYTE, INC. Jun 22, 2023 1 $0 4 Jun 23, 2023 Director
MXCT MAXCYTE, INC. Jun 29, 2022 1 $0 4 Jul 8, 2022 Director
MXCT MAXCYTE, INC. Aug 9, 2021 1 $0 4 Aug 11, 2021 Director
MXCT MAXCYTE, INC. Jul 29, 2021 0 $0 3 Jul 29, 2021 Director